Insmed INSM Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $305.96M+16.0% | $263.84M+85.4% | $142.34M+32.5% | $107.42M+15.7% | $92.82M-11.1% | ||
| $47.42M+7.2% | $44.22M+50.6% | $29.37M+4.6% | $28.08M+31.9% | $21.28M-18.6% | ||
| $209.49M-17.8% | $254.91M+36.7% | $186.42M+5.2% | $177.19M+16.1% | $152.58M-15.1% | ||
| $247.26M+16.4% | $212.48M+14.0% | $186.38M+20.4% | $154.76M+4.9% | $147.55M+3.5% | ||
| $459.28M-21.3% | $583.59M+14.8% | $508.35M+21.0% | $420.29M+23.3% | $340.96M+1.8% | ||
| -$153.32M+52.0% | -$319.75M+12.6% | -$366.01M-17.0% | -$312.88M-26.1% | -$248.14M-7.7% | ||
| -50.1%+71.1pp | -121.2%+136pp | -257.1%+34.1pp | -291.3%-24.0pp | -267.3%-46.7pp | ||
| $20.08M-2.5% | $20.6M+1.1% | $20.38M-4.1% | $21.25M-1.5% | $21.57M+0.1% | ||
| -$736K+59.6% | -$1.82M-202% | -$603K-233% | $453K+243% | $132K— | ||
| -$162.1M+50.4% | -$326.93M+11.3% | -$368.7M-15.1% | -$320.44M-25.3% | -$255.67M-9.1% | ||
| $1.47M-5.5% | $1.55M+17.5% | $1.32M+6.2% | $1.24M+36.3% | $912K-28.0% | ||
| -$163.56M+50.2% | -$328.49M+11.2% | -$370.02M-15.0% | -$321.69M-25.4% | -$256.58M-8.9% | ||
| -53.5%+71.0pp | -124.5%+135pp | -260%+39.5pp | -299.5%-23.1pp | -276.4%-50.9pp | ||
| -$0.76+50.3% | -$1.53+12.6% | -$1.75-2.9% | -$1.70-19.7% | -$1.42-9.2% | ||
| -$148.31M+52.8% | -$314.19M+13.2% | -$362.01M-17.1% | -$309.13M-26.2% | -$244.99M-7.6% | ||
| -48.5%+70.6pp | -119.1%+135pp | -254.3%+33.5pp | -287.8%-23.9pp | -263.9%-45.9pp | ||
| -$153.32M+52.0% | -$319.75M+12.6% | -$366.01M-17.0% | -$312.88M-26.1% | -$248.14M-7.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Insmed's revenue?
- Insmed (INSM) generated $819.6M in revenue over the trailing twelve months, up 115.1% year over year.
- Is Insmed profitable?
- Insmed is not currently profitable: it reported a net loss of $1.2B over the trailing twelve months, a -144.4% net margin.
- What are Insmed's profit margins?
- Gross margin is 81.8% and operating margin is -140.6%, with a -144.4% net margin.
- What is Insmed's earnings per share?
- Insmed's diluted EPS over the trailing twelve months is $-5.74.
- Where does Insmed's income statement data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
